FILE ON PURDUE PHARMA CANADACompany

Purdue Pharma Canada

Payments like this are a rounding error for big drug companies. Canada has no whistleblower-style False Claims Act equivalent2.

5 SOURCES · 12 DOCUMENTED FACTS · 6 DISPUTED · OPENED 2026-07-23 · UPDATED 2026-07-23
On the record see profile →

Payments like this are a rounding error for big drug companies

Canada has no whistleblower-style False Claims Act equivalent

The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
“Canada has no whistleblower-style False Claims Act equivalent (which is what enabled the U.S. case), but Canada's *Food and Drugs Act* could be used.”
VERIFIED — a word-for-word match in the stored source

The agency relied on two internal drug-report searches in May and July 2001 that found no adverse drug reports involving OxyContin.

The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
“The agency relied on two internal drug-report searches in May and July 2001 that "found no adverse drug reports involving OxyContin."”
VERIFIED — a word-for-word match in the stored source

The 2006 revision merely added the word "usually" to the misleading claim — i.e., "Drug abuse is usually not a problem…"

The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
“The 2006 revision merely added the word "**usually**" to the misleading claim — i.e., "Drug abuse is *usually* not a problem…"”
VERIFIED — a word-for-word match in the stored source

Purdue Canada distributed a pain management book to doctors and health professions students at the University of Toronto between 2004 and 2010

Lisa Argyle is affiliated with Purdue and formerly BYU

PASS 4 — The Researchers, The Natural Experiments, and the T
“Lisa Argyle | Purdue (formerly BYU)”
VERIFIED — a word-for-word match in the stored source

National opioid dispensing dropped 14.9% (Feb 2012 – Apr 2016)

The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo
“National opioid dispensing dropped 14.9% (Feb 2012 – Apr 2016);”
VERIFIED — a word-for-word match in the stored source

oxycodone dispensing nationally dropped 46.4% (Gomes et al., 2017)

Fentanyl rose from 25.8% of opioid-related deaths in Ontario in 2012 to nearly 90% by 2021

Purdue Canada paid 100 doctors per year up to $2,000 per talk to go across Canada and talk about pain management to other physicians

OxyContin was approved by Health Canada in 1996

How We Got Here: A Field Guide to the Fentanyl Crisis in Can
“OxyContin — Purdue Pharma's controlled-release oxycodone — was approved by Health Canada in 1996”
VERIFIED — a word-for-word match in the stored source

the longest trial ran only 24 days

How We Got Here: A Field Guide to the Fentanyl Crisis in Can
“the longest trial ran only 24 days”
VERIFIED — a word-for-word match in the stored source
Disputed — who says what, against what see standalone →

These are things people say about Purdue Pharma Canada that aren't settled fact — each one attributed to who's actually claiming it, so a claim never quietly passes as established just because it showed up in a document. Weigh it yourself.

Disputed
"prohibition-style supply intervention without demand-side support produced the fentanyl era"
Unattributed assertion · stance: pro
The evidence on file mostly supports this, but it's still someone's claim, not a settled fact.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
Disputed
"Canada's Food and Drugs Act could be used to send a strong message that this kind of promotional activity is not going to be tolerated"
Asserted by Matthew Herder · stance: pro
Not yet independently weighed — one source's claim, unconfirmed elsewhere.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
Disputed
"Perhaps it's worthwhile to send a strong message that this kind of promotional activity is not going to be tolerated"
Asserted by Matthew Herder · stance: pro
The evidence on file mostly supports this, but it's still someone's claim, not a settled fact.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
Disputed
"Purdue Canada engaged in questionable or even illegal activities in the marketing of OxyContin in Canada"
Asserted by Dr. David Juurlink · stance: neutral
The evidence on file mostly supports this, but it's still someone's claim, not a settled fact.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
Disputed
"did Purdue engage in questionable or even illegal activities in the marketing of OxyContin in Canada?"
Asserted by Dr. David Juurlink · stance: neutral
The evidence on file mostly supports this, but it's still someone's claim, not a settled fact.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
Disputed
"Health Canada's delayed response allowed Purdue to use the misleading information in its promotional materials for more than 10 years (1996–2006)."
Asserted by Itai Bavli · stance: critical
The evidence on file mostly supports this, but it's still someone's claim, not a settled fact.
The Fentanyl Crisis Research Synthesis: Sharpest Evidence fo ↗
1996
1996
approval of OxyContin
1996
OxyContin approval
2001
2001-07
Added Black Box Warning to OxyContin
2006
2006
Health Canada revised the drug's monograph
2007
2007
Class action launched
2012
2012
OxyContin delisting
2012-02
OxyContin replaced with OxyNeo
2020
2020-11
Purdue Pharma bankruptcy
2023
2023
Final approval granted
2018
April 2018
Open letter to Minister of Health
2012
February 2012
reformulation of OxyContin
March 2012
delisting of OxyContin
2018
March 2018
Settlement rejection
2007
May 2007
Purdue Frederick pleads guilty
2017
May 2017
Settlement offer
Show 2 more events
2020
November 2020
Provinces file claim
Undated
null
class-action settled